Limits...
Cost-effectiveness of Out-of-Hospital Continuous Positive Airway Pressure for Acute Respiratory Failure.

Thokala P, Goodacre S, Ward M, Penn-Ashman J, Perkins GD - Ann Emerg Med (2015)

Bottom Line: The patients who survived accrued lifetime quality-adjusted life-years (QALYs) and health care costs according to their age and sex.Costs were accrued through intervention and hospital treatment costs, which depended on patient outcomes.All results were converted into US dollars, using the Organisation for Economic Co-operation and Development purchasing power parities rates.

View Article: PubMed Central - PubMed

Affiliation: School of Health and Related Research, University of Sheffield, Sheffield, United Kingdom. Electronic address: p.thokala@sheffield.ac.uk.

Show MeSH

Related in: MedlinePlus

Cost-effectiveness acceptability curve for the base-case economic analysis.
© Copyright Policy
Related In: Results  -  Collection


getmorefigures.php?uid=PMC4414542&req=5

fig3: Cost-effectiveness acceptability curve for the base-case economic analysis.

Mentions: This is also observed in the cost-effectiveness analysis curve in Figure 3, which shows the proportion of model runs for which each strategy is cost-effective over a range of potential thresholds for willingness to pay. The more we are willing to pay for health gain (ie, the more we are willing to spend to buy a QALY), the more likely it is that out-of-hospital CPAP will be cost-effective, but there is substantial uncertainty between the thresholds of £20,000 per QALY ($29,000/QALY) and £30,000 per QALY ($43,500/QALY).


Cost-effectiveness of Out-of-Hospital Continuous Positive Airway Pressure for Acute Respiratory Failure.

Thokala P, Goodacre S, Ward M, Penn-Ashman J, Perkins GD - Ann Emerg Med (2015)

Cost-effectiveness acceptability curve for the base-case economic analysis.
© Copyright Policy
Related In: Results  -  Collection

Show All Figures
getmorefigures.php?uid=PMC4414542&req=5

fig3: Cost-effectiveness acceptability curve for the base-case economic analysis.
Mentions: This is also observed in the cost-effectiveness analysis curve in Figure 3, which shows the proportion of model runs for which each strategy is cost-effective over a range of potential thresholds for willingness to pay. The more we are willing to pay for health gain (ie, the more we are willing to spend to buy a QALY), the more likely it is that out-of-hospital CPAP will be cost-effective, but there is substantial uncertainty between the thresholds of £20,000 per QALY ($29,000/QALY) and £30,000 per QALY ($43,500/QALY).

Bottom Line: The patients who survived accrued lifetime quality-adjusted life-years (QALYs) and health care costs according to their age and sex.Costs were accrued through intervention and hospital treatment costs, which depended on patient outcomes.All results were converted into US dollars, using the Organisation for Economic Co-operation and Development purchasing power parities rates.

View Article: PubMed Central - PubMed

Affiliation: School of Health and Related Research, University of Sheffield, Sheffield, United Kingdom. Electronic address: p.thokala@sheffield.ac.uk.

Show MeSH
Related in: MedlinePlus